South Shore Capital Advisors

Position in LLY — ELI LILLY & Co

CIK 1852993 COHASSET, MA

Position in LLY

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$464,179

+$129,383 QoQ

Shares Held

387

+6.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#3,814

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

South Shore Capital Advisors holds $5,027,059 across 5 Drug Manufacturers - General names. LLY ranks #2 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	13,605	$3,455,261
2	LLY	ELI LILLY & Co This page	387	$464,179
3	NVS	Novartis AG	2,870	$449,786
4	MRK	Merck & Co., Inc.	3,498	$449,493
5	PFE	Pfizer Inc	8,652	$208,340

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$464,179	387	+6.3%	Shares	Sole	2026-07-30
2026-03-31	$334,796	364	+91.6%	Shares	Sole	2026-04-28
2025-12-31	$204,189	190	—	Shares	Sole	2026-01-21
No filing history on record for this holder in this stock.